We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+28.45%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$452B
AUM Growth
+$83.8B
Cap. Flow
-$1.84B
Cap. Flow %
-0.41%
Top 10 Hldgs %
16.9%
Holding
6,941
New
185
Increased
3,288
Reduced
2,645
Closed
222

Sector Composition

Rank Sector Weight
1 Technology 19.32%
2 Healthcare 10.4%
3 Consumer Discretionary 8.1%
4 Communication Services 7.82%
5 Financials 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EBIZ icon
6001
Global X E-commerce ETF
EBIZ
$28.4M
$9K ﹤0.01%
373
-5,707
-94% -$115K
EEMO icon
6002
Invesco S&P Emerging Markets Momentum ETF
EEMO
$22.8M
$9K ﹤0.01%
655
FGNX
6003
FG Nexus Inc
FGNX
$41.6M
$9K ﹤0.01%
16
-63
-80% -$36.7K
FPAY
6004
DELISTED
FlexShopper
FPAY
$9K ﹤0.01%
5,100
-73,101
-93% -$99.9K
IGRO icon
6005
iShares International Dividend Growth ETF
IGRO
$1.3B
$9K ﹤0.01%
171
NFLT icon
6006
Virtus Newfleet Multi-Sector Bond ETF
NFLT
$447M
$9K ﹤0.01%
+358
New +$8.37K
PNBK icon
6007
Patriot National Bancorp
PNBK
$134M
$9K ﹤0.01%
1,500
SHYL icon
6008
Xtrackers Short Duration High Yield Bond ETF
SHYL
$267M
$9K ﹤0.01%
+199
New +$8.81K
SLS icon
6009
SELLAS Life Sciences
SLS
$1.97B
$9K ﹤0.01%
3,065
-31,831
-91% -$86.3K
SVT
6010
DELISTED
Servotronics
SVT
$9K ﹤0.01%
1,200
WULF icon
6011
TeraWulf
WULF
$8.75B
$9K ﹤0.01%
2,500
XTNT icon
6012
Xtant Medical Holdings
XTNT
$60.3M
$9K ﹤0.01%
9,701
UFAB
6013
DELISTED
Unique Fabricating, Inc.
UFAB
$9K ﹤0.01%
2,800
-2,000
-42% -$6.21K
CYTO
6014
DELISTED
Altamira Therapeutics Ltd
CYTO
$9K ﹤0.01%
24
-13
-35% -$4.88K
INFI
6015
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$9K ﹤0.01%
9,556
+1,640
+21% +$1.56K
CHRA
6016
DELISTED
Charah Solutions, Inc Common Stock
CHRA
$9K ﹤0.01%
296
+212
+252% +$3.68K
DWPP
6017
DELISTED
First Trust Dorsey Wright People's Portfolio ETF
DWPP
$9K ﹤0.01%
360
LEJU
6018
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
$9K ﹤0.01%
510
+49
+11% +$860
ZSAN
6019
DELISTED
Zosano Pharma Corporation
ZSAN
$9K ﹤0.01%
295
-39
-12% -$1.1K
ADXS
6020
DELISTED
Advaxis Inc
ADXS
$9K ﹤0.01%
16,923
+5,015
+42% +$3.37K
SVA
6021
DELISTED
Sinovac Biotech, Ltd
SVA
$9K ﹤0.01%
1,400
PLLL
6022
DELISTED
Piedmont Lithium Limited American Depositary Receipts
PLLL
$9K ﹤0.01%
1,516
+607
+67% +$3.6K
AEHR icon
6023
Aehr Test Systems
AEHR
$2.61B
$8K ﹤0.01%
4,200
AQMS icon
6024
Aqua Metals
AQMS
$8.99M
$8K ﹤0.01%
28
+2
+8% +$312
ARMP icon
6025
Armata Pharmaceuticals
ARMP
$167M
$8K ﹤0.01%
1,992

Similar funds

Morgan Stanley's Q2 2020 Portfolio in Review

As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
  • Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
  • Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
  • Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
  • Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
  • Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
  • Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.

Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.